Toward better management of rare and orphan pulmonary diseases
Open Access
- 30 April 2016
- journal article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 47 (5) , 1334-1335
Abstract
Efforts deployed by the ERS and its publications to promote rare disease and orphan drug research http://ow.ly/YNbNNKeywords
This publication has 18 references indexed in Scilit:
- Pulmonary veno-occlusive diseaseEuropean Respiratory Journal, 2016
- The changing face of a rare disease: lymphangioleiomyomatosisEuropean Respiratory Journal, 2015
- Interstitial lung disease in systemic sclerosis: where do we stand?European Respiratory Review, 2015
- Idiopathic pulmonary fibrosis: from clinical trials to real-life experiencesEuropean Respiratory Review, 2015
- Pulmonary hypertension in patients with chronic myeloproliferative disordersEuropean Respiratory Review, 2015
- Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretationEuropean Respiratory Review, 2015
- Smoking and interstitial lung diseasesEuropean Respiratory Review, 2015
- Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigmEuropean Respiratory Journal, 2015
- A new era in idiopathic pulmonary fibrosis: considerations for future clinical trialsEuropean Respiratory Journal, 2015
- Rare (pulmonary) disease day: “feeding the breath, energy for life!”European Respiratory Journal, 2015